FDA approves X4 Pharmaceuticals pill for ultrarare immunodeficiency disease Endpoints News

X4 Phar­ma­ceu­ti­cals an­nounced Mon­day morn­ing that the FDA ap­proved its dai­ly pill for WHIM syn­drome — an ul­tra-rare im­mune dis­ease named af­ter its symp­toms. The pill, ma­vorix­afor, wa… [+516 chars]Read More